Publications
“Influence of human skin specimens consisting of different skin layers on the result of in vitro permeation experiments.”, Skin Pharmacology and Physiology, vol. 21, no. 2, pp. 81-8, 2008.
, “In-silico model of skin penetration based on experimentally determined input parameters. Part I: experimental determination of partition and diffusion coefficients.”, European Journal of Pharmaceutics and Biopharmaceutics, vol. 68, no. 2, pp. 352-67, 2008.
, “In-silico model of skin penetration based on experimentally determined input parameters. Part II: mathematical modelling of in-vitro diffusion experiments. Identification of critical input parameters.”, European Journal of Pharmaceutics and Biopharmaceutics, vol. 68, no. 2, pp. 368-79, 2008.
, “Mimotopes identify conformational B-cell epitopes on the two major house dust mite allergens Der p 1 and Der p 2.”, Molecular Immunology, vol. 45, no. 5, pp. 1308-17, 2008.
, “5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease.”, Journal of Controlled Release, vol. 123, no. 3, pp. 211-8, 2007.
, “Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.”, Bioconjugate Chemistry, vol. 18, no. 4, pp. 1087-94, 2007.
, “Development of a fluorescence-based assay for screening of modulators of human organic anion transporter 1B3 (OATP1B3).”, European Journal of Pharmaceutics and Biopharmaceutics, vol. 62, no. 1, pp. 39-43, 2006.
, “A fully computational model for predicting percutaneous drug absorption.”, Journal of Chemical Information and Modeling, vol. 46, no. 1, pp. 424-9, 2006.
, “Human vascular endothelial cells in primary cell culture for the evaluation of nanoparticle bioadhesion.”, Journal of Nanoscience and Nanotechnology, vol. 6, no. 9-10, pp. 3303-9, 2006.
, “Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells”, Nanotechnology, vol. 17, no. 15, p. 3673, 2006.
,